vimarsana.com

Page 72 - பல்கலைக்கழகம் ஆஃப் கலிஃபோர்னியா லாஸ் ஏஞ்சல்ஸ் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The new leader of the nation s coronavirus fight has been battling diseases her whole career

The new leader of the nation’s coronavirus fight has been battling diseases her whole career Laura Krantz © Kate Flock/MGH Dr. Rochelle Walensky. The unit where Dr. Rochelle Walensky performed her residency, during the peak of the AIDS epidemic in Baltimore, held a standing memorial service every two weeks because so many of its patients were dying. It was a grueling start to a medical career, when young trainees worked 100-hour weeks at Johns Hopkins Hospital, holding the hands of people succumbing to a virus for which there was not yet any treatment. “In 1995 we told patients with AIDS they would, with certainty, die,” Walensky said in 2019 testimony before Congress. Since those early days, the physician has had a meteoric rise at Massachusetts General Hospital, including being appointed just the third chief and the first woman to lead the Division of Infectious Diseases since its inception in 1956.

Opinion: A Muslim scholar says human rights policy needs to focus on religious scholars

Story highlights He was speaking at a virtual conference, organized by the Washington-based Arab Center for Law and Research to focus attention on another popular but controversial religious scholar A prominent Muslim scholar has warned that the West’s failure to include the incarceration in Saudi Arabia and elsewhere in the Muslim world of pro-democracy religious scholars risks perpetuating autocratic rule. “The world manufactures the condition that it condemns. We don’t rise up to condemn the persecution of Muslim democrats when it occurs, and we don’t go out of our way to protect Muslim democrats. In fact, there is a deeply embedded hypocrisy when it comes to the Muslim world,” said Khaled Abou el Fadel, a Kuwait-born University of California Los Angeles (UCLA) Islamic law professor and human rights activist.

Will Snow Be Used in the Future for Renewable Energy?

Study shows efficacy of radionuclide therapy–immunotherapy combination in prostate cancer model

Study shows efficacy of radionuclide therapy–immunotherapy combination in prostate cancer model A combination of radionuclide therapy and immunotherapy has proven successful in slowing the progression of prostate cancer and increasing survival time, according to new research published in the February issue of The Journal of Nuclear Medicine. The results of the murine study indicate that radionuclide therapy promotes prostate cancer immunogenicity, provoking a cellular response that makes the tumors more receptive to immunotherapy. Prostate cancer is generally viewed as an immunological cold cancer in which immunotherapies only have moderate success. Increasing prostate cancer immunogenicity with prostate-specific membrane antigen (PSMA) radionuclide therapy, however, might render immunotherapies more successful. In our research we sought to exploit this effect by combining radionuclide therapy with immunotherapy in a mouse model of prostate cancer.

UCLA In the News February 9, 2021

February 9, 2021 UCLA In the News lists selected mentions of UCLA in the world’s news media. Some articles may require registration or a subscription to view. See more UCLA In the News. “We as an engineering community learned from that, that just having strength was not enough,” said Jonathan Stewart, professor of civil and environmental engineering at UCLA. “You had to have ductility” the ability to stretch. “The [building] code would essentially produce nonductile concrete buildings.” A new archival project at UCLA seeks to become that conduit, using boxes and boxes of internal records obtained by the LAPD. And to further that mission, the effort was recently given a three-and-a-half million-dollar boost in the form of a grant. Kelly Lytle Hernandez and Mark Vestal are professors at UCLA. They also head this new project, called Archiving the Age of Mass Incarceration. (Lytle Hernandez and Vestal were interviewed.)

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.